Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 11/2022

20.04.2022 | Short Communication

Hepatocellular carcinoma radiation segmentectomy treatment intensification prior to liver transplantation increases rates of complete pathologic necrosis: an explant analysis of 75 tumors

verfasst von: S. Ali Montazeri, Cynthia De la Garza-Ramos, Andrew R. Lewis, Jason T. Lewis, Jordan D. LeGout, David M. Sella, Ricardo Paz-Fumagalli, Zlatko Devcic, Charles A. Ritchie, Gregory T. Frey, Lucas Vidal, Kristopher P. Croome, J. Mark McKinney, Denise Harnois, Sunil Krishnan, Tushar Patel, Beau B. Toskich

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 11/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To verify the correlation between yttrium-90 glass microsphere radiation segmentectomy treatment intensification of hepatocellular carcinoma (HCC) and complete pathologic necrosis (CPN) at liver transplantation.

Methods

A retrospective, single center, analysis of patients with HCC who received radiation segmentectomy prior to liver transplantation from 2016 to 2021 was performed. The tumor treatment intensification cohort (n = 38) was prescribed radiation segmentectomy as per response recommendations identified in a previously published baseline cohort study (n = 37). Treatment intensification and baseline cohort treatment parameters were compared for rates of CPN. Both cohorts were then combined for an overall analysis of treatment parameter correlation with CPN.

Results

Sixty-three patients with a combined 75 tumors were analyzed. Specific activity, dose, and treatment activity were significantly higher in the treatment intensification cohort (all p < 0.01), while particles per cubic centimeter of treated liver were not. CPN was achieved in 76% (n = 29) of tumors in the treatment intensification cohort compared to 49% (n = 18) in the baseline cohort (p = 0.013). The combined cohort CPN rate was 63% (n = 47). ROC analysis showed that specific activity ≥ 327 Bq (AUC 0.75, p < 0.001), dose ≥ 446 Gy (AUC 0.69, p = 0.005), and treatment activity ≥ 2.55 Gbq (AUC 0.71, p = 0.002) were predictive of CPN. Multivariate logistic regression demonstrated that a specific activity ≥ 327 Bq was the sole independent predictor of CPN (p = 0.013).

Conclusion

Radiation segmentectomy treatment intensification for patients with HCC prior to liver transplantation increases rates of CPN. While dose strongly correlated with pathologic response, specific activity was the most significant independent radiation segmentectomy treatment parameter associated with CPN.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Garin E, Tselikas L, Guiu B, et al. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial. Lancet Gastroenterol Hepatol. 2021;6(1):17–29. https://doi.org/10.1016/S2468-1253(20)30290-9. Garin E, Tselikas L, Guiu B, et al. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial. Lancet Gastroenterol Hepatol. 2021;6(1):17–29. https://​doi.​org/​10.​1016/​S2468-1253(20)30290-9.
5.
Zurück zum Zitat DiNorcia J, Florman SS, Haydel B, et al. Pathologic response to pretransplant locoregional therapy is predictive of patient outcome after liver transplantation for hepatocellular carcinoma: analysis from the US Multicenter HCC Transplant Consortium. Ann Surg. 2020;271(4):616–24. https://doi.org/10.1097/SLA.0000000000003253. DiNorcia J, Florman SS, Haydel B, et al. Pathologic response to pretransplant locoregional therapy is predictive of patient outcome after liver transplantation for hepatocellular carcinoma: analysis from the US Multicenter HCC Transplant Consortium. Ann Surg. 2020;271(4):616–24. https://​doi.​org/​10.​1097/​SLA.​0000000000003253​.
10.
12.
Zurück zum Zitat Field A. Discovering statistics using IBM SPSS statistics 5th Ed. 2018. Field A. Discovering statistics using IBM SPSS statistics 5th Ed. 2018.
13.
Zurück zum Zitat Hahs-Vaughn, D. LomaX R. An introduction to statistical concepts. 2013. Hahs-Vaughn, D. LomaX R. An introduction to statistical concepts. 2013.
14.
Zurück zum Zitat Field A. Discovering statistics using IBM SPSS statistics. 2013. Field A. Discovering statistics using IBM SPSS statistics. 2013.
15.
Zurück zum Zitat De la Garza-Ramos C, Overfield CJ, Montazeri SA, et al. Biochemical safety of ablative yttrium-90 radioembolization for hepatocellular carcinoma as a function of percent liver treated. J Hepatocell Carcinoma. 2021;8:861–70. https://doi.org/10.2147/JHC.S319215. De la Garza-Ramos C, Overfield CJ, Montazeri SA, et al. Biochemical safety of ablative yttrium-90 radioembolization for hepatocellular carcinoma as a function of percent liver treated. J Hepatocell Carcinoma. 2021;8:861–70. https://​doi.​org/​10.​2147/​JHC.​S319215.
Metadaten
Titel
Hepatocellular carcinoma radiation segmentectomy treatment intensification prior to liver transplantation increases rates of complete pathologic necrosis: an explant analysis of 75 tumors
verfasst von
S. Ali Montazeri
Cynthia De la Garza-Ramos
Andrew R. Lewis
Jason T. Lewis
Jordan D. LeGout
David M. Sella
Ricardo Paz-Fumagalli
Zlatko Devcic
Charles A. Ritchie
Gregory T. Frey
Lucas Vidal
Kristopher P. Croome
J. Mark McKinney
Denise Harnois
Sunil Krishnan
Tushar Patel
Beau B. Toskich
Publikationsdatum
20.04.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 11/2022
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-022-05776-y

Weitere Artikel der Ausgabe 11/2022

European Journal of Nuclear Medicine and Molecular Imaging 11/2022 Zur Ausgabe